StandoutStocks.com: StandoutStocks.com "Stocks that Standout" today are: ADRM, ALYI, ARIO, BDTE, EREI

Aug 07, 2008 (M2 PRESSWIRE via COMTEX) -- EREI | Quote | Chart | News | PowerRating -- StandoutStocks.com "Stocks that Standout" today are: Aduromed Industries, Inc. (OTCBB: ADRM), Alternet Systems, Inc. (OTCBB: ALYI), AmeriResource Technologies, Inc. (OTCBB: ARIO), Brendan Technologies, Inc. (OTCBB: BDTE), EAGLE ROCK ENTERPRISES, INC. (PINKSHEETS: EREI), and Proudly Introducing Proprietary Push Technology (PPT).

The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration.

http://newmediaadvisors.info/newmedia.swf

Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com

Aug 06, 2008 -- Aduromed Industries, Inc. (OTCBB: ADRM | Quote | Chart | News | PowerRating) a leading manufacturer of medical waste treatment systems, today announced the closing of its previously announced restructuring plan and the raise of $3.8 million of new equity capital. As part of the restructuring all stakeholders in the Company, including holders of bridge loan notes and preferred stock holders, converted their securities into common stock of the Company and warrants to purchase common stock. New Investors received 271,497,456 shares of common stock and warrants to purchase an additional 235,497,455 shares of common stock at a purchase price of $0.025 for their $3.8 million investment. Existing investors in the Company converted their securities into a total of 137,693,121 shares of common stock and warrants to purchase an additional 173,693,122 shares of common stock at a purchase price of $0.025.

The Company will use the funds for working capital and general corporate purposes and to help implement the Company's new business plan. The Company will have further announcements concerning the new business plan in the near future. As a result of this restructuring, the Company now has 431 million shares outstanding.

As part of the restructuring, Mr. Joseph Esposito was elected as a director and Chairman of the Board of the Company. Mr. Esposito also entered into a new consulting agreement to act as corporate and business development advisor to the Company for an additional three year period. Mr. Esposito brings a broad background of over 30 years of managing the growth and profitability of domestic and international technology companies. For the past two years he has been providing strategic advisory services to growth companies including several of the portfolio companies at Insight Venture Partners, a private equity firm with more than $1.5 billion under management. Prior to this he was President and CEO of eResearch Technology, Inc., a leading provider of technology and services to collect, process, and distribute cardiac safety and clinical data for companies in the life sciences industry. During his tenure as President and CEO from 2001 through 2006, eResearch's market valuation grew from $27 million to a peak of $1.5 billion, receiving recognition from Fortune Magazine as the second fastest growing company in America.

"Aduromed today achieved an important milestone event, setting the stage for the Company to emerge as a leader in the medical waste disposal industry, a $2 billion annual market in the US alone," Mr. Esposito commented. "I am excited to assume a leadership role in this organization at this point in its development, and believe that the core assets of the current organization will enable Aduromed to build a more predictable business model that appeals to a broader market."

Mr. Damien Tanaka, founder of the Company, was elected as Vice-Chairman of the Board of the Company and will continue as a director of Company. Mr. Tanaka will be the acting Chief Executive Officer of the Company pending the naming of a new President and Chief Executive Officer which is expected shortly. After such announcement Mr. Tanaka will assume the title of Chief Development Officer and will spearhead the Company's new product developments.

"I welcome Joe Esposito to Aduromed and I am excited to have the opportunity to benefit from his managerial and business development expertise," Mr. Tanaka added. "Over the past decade, Aduromed has developed unique and compelling technology and services to address the $2 billion medical waste industry. With this announcement, Aduromed moves to the next level in this evolution, and we stand poised to emerge as the industry leader with new technologies which we believe will capture market share while establishing best practice in medical waste disposal."

About Aduromed

Aduromed Industries, Inc., through its wholly-owned subsidiary, Aduromed Corporation, is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. Aduromed's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste.

Aduromed was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut.

Aug 06, 2008 -- Alternet Systems, Inc. (OTCBB: ALYI | Quote | Chart | News | PowerRating) CEO Henryk Dabrowski yesterday conducted a corporate overview Webcast to discuss the Company's E-Ticketing Solution, strategic partnerships and concentration on expanding its service offerings in the Latin American market. During the Webcast, Mr. Dabrowski presented the Company's pending first major E-Ticket contract and the anticipated $24 million in revenue for fiscal year 2009 as a result of the contract. Alternet's current annual revenue run rate is approximately $3 million.

An archive of the Webcast is available at http://www.investorcalendar.com/IC/CEPage.asp?ID=132993.

Alternet has recently launched a communications campaign in conjunction with the roll out of its proprietary E-Ticket solution. A new Investor Fact Sheet highlighting the Company's recent acquisition of TekVoice Communications, E-Transaction technology, mass transportation management services and strategic partnerships is now available.

In 2007, the Company was restructured through an acquisition of a technology asset key to its current E-Transaction service strategy. Highlights of the Company's financials include:

-- The issued and outstanding today is under 12 million shares -- The Company reported over $3 million in revenue in 2007 -- Gross Margins in 2007 were over 50%

If you are interested in receiving a copy of the Investor Fact Sheet call 214-556-5927 or send an e-mail to Red River Advisors, at alternet@redriveradvisors.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

About Alternet Systems

Alternet Systems, Inc. provides telecommunications services, education and health-care application software and systems, and electronic transaction platforms for the mass transportation and utility markets. Alternet Systems is a U.S. corporation with offices in Miami, Florida and Vancouver, British Columbia, Canada.

ug 06, 2008 -- AmeriResource Technologies, Inc. (OTCBB: ARIO | Quote | Chart | News | PowerRating) announced that its subsidiary, RoboServer Systems Corp. (PINKSHEETS: RBSY), has established a new product and revenue center to serve city/government agencies and private corporations.

Delmar Janovec, CEO of AmeriResource comments, "RoboServer has created a new product line and revenue center, RoboServer Easy Pay. This newly created division of RoboServer offers a portfolio of customized integrated software applications. Examples include the processing of payments for utilities (water, electricity, and natural gas bills), franchise or property taxes, parking or speeding tickets, and many other opportunities for self-service payment processing. RoboServer Easy Pay is fully compatible with RoboServer stand-alone touch-screen kiosk models or RoboServer's innovative Assisted-Server Dual Screen counter-top model. The software application is very intuitive and fluid to provide the customer with a complete and satisfactory transaction while reducing costs and increasing productivity for the owner, whether private or governmental."

Company information is available at http://www.RoboServerCorp.com. Investors and media can receive a free investor kit for RoboServer Systems Corp. by contacting Investor Relations at investors@roboservercorp.com or (866) 893-0229. Company financial statements can be viewed at www.PinkSheets.com.

ABOUT ROBOSERVER SYSTEMS:

RoboServer Systems Corp. (PINKSHEETS: RBSY), is a software developer and touch-screen system integrator for kiosks and other networking units that support point of sale (P.O.S.), self-service ordering and payment processing functions. In addition to kiosk hardware, operating system software, and client-defined customized touch-screen software applications, RoboServer can provide installation, training, software updates, and ongoing maintenance and support. RoboServer is the one-stop provider of self-service solutions for multiple industries.

ABOUT AMERIRESOURCE:

AmeriResource is a diversified holding company with headquarters in Las Vegas, Nevada. It operates RoboServer Systems Corp. (PINKSHEETS: RBSY), BizAuctions, Inc. (PINKSHEETS: BZCN), and AuctionWagon, Inc. ("AWI"), as operating subsidiaries.

Aug 06, 2008 -- While Brendan Technologies, Inc. (OTCBB: BDTE), an innovative analytical software company, is completing the development of its powerful new assay analysis software, STATLIA(R) Quantum, one of the world's top ten pharmaceutical companies has already made an advance purchase of the system for one of its worldwide locations. Neither the terms of the agreement nor the company's name was disclosed.

Brendan Technologies also has already inked a license agreement for STATLIA Quantum with Invitrogen (NASDAQ:IVGN) to facilitate the analysis of protein samples.

STATLIA Quantum offers "quantum leap" advancement in assay analysis software due to its scalability, flexibility, and industry-leading computational analysis tools. Written in an advanced architectural design on a .NET framework, the new software can be centrally administered throughout an organization by the IT department. It has the flexibility to analyze multiple technologies and applications in the laboratory, along with offering a number of unique analysis tools made possible by its advanced and proprietary computational capabilities.

"This purchase adds to the confirmation that STATLIA Quantum is well positioned in the biopharmaceutical industry to address currently unmet critical needs for assay analysis," said John Dunn, PhD, Chief Executive Officer of Brendan Technologies. "The fact that major industry players are willing to make pre-release purchases of STATLIA Quantum underscores the need for the unique and advanced assay analysis capabilities that this software brings to the drug development process."

One of the industry's leading experts in the field of immunoassay and bioassay testing, Dr. Dunn serves as an IBC Life Sciences instructor teaching comprehensive training courses on the subject of "Analyzing Biological Assays" to the biopharmaceutical industry, and has authored several key papers on the subject. He has been invited by the United States Pharmacopeia (USP) regulatory agency to make a presentation at its annual USP Bioassay Workshop held August 14 on three methods used for drug potency testing. Brendan has incorporated all three methods under discussion in its new STATLIA Quantum software.

About Brendan Technologies, Inc.

Brendan Technologies, a developer and marketer of innovative analytical software, is actively providing software solutions to improve the accuracy, quality control, workflow, and regulatory compliance of immunoassay and bioassay testing in laboratories in the biopharmaceutical, clinical, research, veterinarian and agricultural industries. The Company's customers, many of whom are Fortune 1000 organizations, represent some of the largest corporations in their respective fields. Brendan Technologies is continually redesigning and expanding its product lineup to better capitalize on the growing demand of its target markets for more advanced software.

Background on Immunoassay Testing

Immunoassays are one of the world's largest and fastest growing testing technologies used to diagnose diseases, discover new chemical entities and biological products, provide vital data in the development of drugs in FDA clinical trials, and assist in quality control of drug manufacturing and drug screening. It is also one of the largest technologies used in environmental testing. Currently, $50 billion is spent globally on immunoassay testing, with approximately $1 billion of that being spent on immunoassay software.

Immunoassays are highly sensitive and specific chemical tests used to detect and quantify extremely minute substances in blood, body fluid and other biological samples, using an immunological reaction. These tests measure the formation of antibody-antigen complexes and detect them via an indicator reaction. Their high specificity results from the use of antibodies and purified antigens as reagents. High sensitivity is achieved by using an indicator system that results in amplification of the measured product. Immunoassays may be qualitative (positive or negative) or quantitative (amount measured).

Aug 05, 2008 -- EAGLE ROCK ENTERPRISES, INC. (PINKSHEETS: EREI | Quote | Chart | News | PowerRating) (EAGLE ROCK) is pleased to announce a strategic partnership with the BLIND VENDORS OF ILLINOIS. John Gordon, President of the Illinois Committee of Blind Vendors for 12 years and First Vice President of the Randolph Sheppard Organization stated, "The purchasing economics of the NATIONAL BLIND ENTERPRISES CO-OP (a subsidiary of EAGLE ROCK) allows our vendors to maximize their sales volume potential and coordinate their inventory needs."

Gordon further added, "The quarterly reports from our distributors will reflect significant increases for the major brands such as M&M, Pepsi, Frito-lay, Kraft, Kellogg's and others involved in EAGLE ROCK's national Plan-O-Gram program."

About Standoutstocks.com

Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.

Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx

CONTACT: Standoutstocks.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index